162 related articles for article (PubMed ID: 7587032)
1. Prospective evaluation of twice-daily cefotaxime in the treatment of hospitalized patients with severe infections.
Keller C
Diagn Microbiol Infect Dis; 1995; 22(1-2):159-61. PubMed ID: 7587032
[TBL] [Abstract][Full Text] [Related]
2. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
Shah PM; Stille W
Diagn Microbiol Infect Dis; 1995; 22(1-2):171-2. PubMed ID: 7587035
[TBL] [Abstract][Full Text] [Related]
3. Study of cefotaxime twice daily for the therapy of postoperative pneumonia. The German Cefotaxime Study Group.
Bruch HP; Kujath P
Diagn Microbiol Infect Dis; 1995; 22(1-2):203-7. PubMed ID: 7587041
[TBL] [Abstract][Full Text] [Related]
4. Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations.
Fernández-Guerrero M; Gudiol F; Rodriguez-Torres A; Arnau C; Valdés L; Vallvé C
Infection; 1991; 19 Suppl 6():S320-5. PubMed ID: 1791077
[TBL] [Abstract][Full Text] [Related]
5. The choice of antibacterial drugs.
Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
[No Abstract] [Full Text] [Related]
6. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of severe infections: should one always administer an aminoglycoside?].
Cometta A; Baumgartner JD
Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Robert R; Grollier G; Doré P; Hira M; Ferrand E; Fauchère JL
J Crit Care; 1999 Sep; 14(3):114-9. PubMed ID: 10527248
[TBL] [Abstract][Full Text] [Related]
9. [Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections].
Nonikov VE; Konstantinova TD; Lenkova NI; Minaev VI; Ritchik LA
Antibiot Khimioter; 1997; 42(10):15-8. PubMed ID: 9412397
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of twice-daily cefotaxime compared to conventional therapy for the treatment of infections in a USA hospital.
Burke JP; Pestotnik SL; Classen DC; Lloyd JF
Diagn Microbiol Infect Dis; 1995; 22(1-2):167-9. PubMed ID: 7587034
[TBL] [Abstract][Full Text] [Related]
11. Ceftobiprole for the treatment of pneumonia.
Cillóniz C; Dominedò C; Garcia-Vidal C; Torres A
Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):17-23. PubMed ID: 31364337
[TBL] [Abstract][Full Text] [Related]
12. Cephalosporin therapeutics for intensive care infections.
Salacata A; Chow JW
New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Beaucaire G
J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
[TBL] [Abstract][Full Text] [Related]
14. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
Alvarez-Lerma F; Insausti-Ordeñana J; Jordá-Marcos R; Maraví-Poma E; Torres-Martí A; Nava J; Martínez-Pellús A; Palomar M; Barcenilla F;
Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
[TBL] [Abstract][Full Text] [Related]
17. The choice of antibacterial drugs.
Med Lett Drugs Ther; 1996 Mar; 38(971):25-34. PubMed ID: 8598824
[No Abstract] [Full Text] [Related]
18. Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections.
Boccazzi A; Tonelli P; Bellosta C; Careddu P
Diagn Microbiol Infect Dis; 1998 Dec; 32(4):265-72. PubMed ID: 9934543
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial treatment of invasive mechanical ventilation-associated pneumonia.
Barcenilla F; Gascó E; Rello J; Alvarez-Rocha L
Drugs Aging; 2001; 18(3):189-200. PubMed ID: 11302286
[TBL] [Abstract][Full Text] [Related]
20. Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study.
Manhold C; von Rolbicki U; Brase R; Timm J; von Pritzbuer E; Heimesaat M; Kljucar S
Intensive Care Med; 1998 Dec; 24(12):1327-30. PubMed ID: 9885888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
